TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 93 filers reported holding TCR2 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $575,229 | +21.6% | 383,486 | -19.0% | 0.00% | – |
| Q4 2022 | $472,916 | +47191.6% | 473,484 | +103055.6% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 459 | -55.7% | 0.00% | – |
| Q2 2022 | $3,000 | -50.0% | 1,035 | -51.7% | 0.00% | – |
| Q1 2022 | $6,000 | -85.4% | 2,142 | -75.9% | 0.00% | – |
| Q4 2021 | $41,000 | -90.4% | 8,876 | -82.3% | 0.00% | – |
| Q3 2021 | $426,000 | -83.9% | 50,023 | -69.0% | 0.00% | -100.0% |
| Q2 2021 | $2,644,000 | -22.1% | 161,146 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $3,392,000 | +819.2% | 153,642 | +1186.6% | 0.00% | – |
| Q4 2020 | $369,000 | +897.3% | 11,942 | +560.5% | 0.00% | – |
| Q3 2020 | $37,000 | -21.3% | 1,808 | -40.3% | 0.00% | – |
| Q2 2020 | $47,000 | 0.0% | 3,028 | -50.0% | 0.00% | – |
| Q1 2020 | $47,000 | +6.8% | 6,060 | +98.8% | 0.00% | – |
| Q4 2019 | $44,000 | +340.0% | 3,049 | +324.7% | 0.00% | – |
| Q3 2019 | $10,000 | +42.9% | 718 | +56.8% | 0.00% | – |
| Q2 2019 | $7,000 | -82.1% | 458 | -79.6% | 0.00% | – |
| Q1 2019 | $39,000 | – | 2,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |